# Tempus Priority Study: A Pan-tumor Observational Study

> **NCT05179824** · — · ACTIVE_NOT_RECRUITING · sponsor: **Tempus AI** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer
- Prostate Cancer
- Bladder Cancer
- Lung Cancer
- Brain Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer
- Cancer of Liver
- Cancer of Colon
- Cancer of Head and Neck
- Cancer of Stomach
- Cancer of Gastrointestinal Tract
- Cancer of Rectum
- Cancer of Esophagus
- Cancer of Skin
- Cancer of Cervix
- Cancer of Kidney
- Cancer of Larynx
- Cancer of Endometrium
- Cancer of the Bile Duct
- Cancer of Vulva
- Cancer of Bone and Connective Tissue
- Leukemia
- Lymphoma
- Spinal Cord Cancer

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT05179824
- **Lead sponsor:** Tempus AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-19
- **Primary completion:** 2026-10-19
- **Final completion:** 2030-10-19
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179824, "Tempus Priority Study: A Pan-tumor Observational Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05179824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*